Merck expansion plans for India
International pharmaceutical and chemical company Merck is continuing plans to expand in the Indian market but has stated it will not introduce any high-tech, patented products through its listed Indian subsidiary, Merck Ltd, in which it has a 51% stake.
International pharmaceutical and chemical company Merck is continuing plans to expand in the Indian market but has stated it will not introduce any high-tech, patented products through its listed Indian subsidiary, Merck Ltd, in which it has a 51% stake.
Apparently Merck intends to use its wholly-owned subsidiary, Merck Specialities, for this purpose, and the subsidiary would also be used as a sourcing hub for the Asian markets. Merck stated that this is in line with its strategy in other parts of the world.
The initial focus of the subsidiary would be to deal in highly innovative and specialised pharmaceutical products.
Industry analysts consider that government approval for the company's proposal will be assisted by the fact that the Merck Ltd board has already provided a no-objection certificate to Merck Holdings for setting up the proposed subsidiary.